These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4276583)

  • 1. Proceedings: Thyrotropin-releasing hormone: activation of cerebral noradrenaline turnover.
    Keller HH; Bartholini G
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R46. PubMed ID: 4276583
    [No Abstract]   [Full Text] [Related]  

  • 2. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone.
    Keller HH; Bartholini G; Pletscher A
    Nature; 1974 Apr; 248(448):528-9. PubMed ID: 4207412
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):743-52. PubMed ID: 12549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurotransmitters and hypothalamic hormones in the central nervous system.
    Brownstein M
    Fed Proc; 1977 Jun; 36(7):1960-3. PubMed ID: 16784
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of taltirelin hydrate (TA-0910), a novel thyrotropin-releasing hormone analog, on in vivo dopamine release and turnover in rat brain.
    Fukuchi I; Asahi T; Kawashima K; Kawashima Y; Yamamura M; Matsuoka Y; Kinoshita K
    Arzneimittelforschung; 1998 Apr; 48(4):353-9. PubMed ID: 9608876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological analysis of shaking behavior induced by enkephalins, thyrotropin-releasing hormone or serotonin in rats: evidence for different mechanisms.
    Drust EG; Connor JD
    J Pharmacol Exp Ther; 1983 Jan; 224(1):148-54. PubMed ID: 6401333
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of locomotor activity and catecholamine and 5-hydroxytryptamine metabolism by thyrotropin releasing hormone.
    Agarwal RA; Rastogi RB; Singhal RL
    Neuroendocrinology; 1977; 23(4):236-47. PubMed ID: 409963
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of brain noradrenaline and dopamine turnover by thyrotropin-releasing hormone and its analogue NS-3 in mice and rats.
    Itoh Y; Yamazaki A; Ukai Y; Yoshikuni Y; Kimura K
    Pharmacol Toxicol; 1996 Jun; 78(6):421-8. PubMed ID: 8829205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin-releasing hormone--increased catabolism of catecholamines in brains of thyroidectomized rats.
    Marek K; Haubrich DR
    Biochem Pharmacol; 1977 Oct; 26(19):1817-8. PubMed ID: 410420
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of neonatal thyroid deficiency on the catecholamine, substance P, and thyrotropin-releasing hormone contents of discrete rat brain nuclei.
    Dupont A; Dussault JH; Rouleau D; DiPaolo T; Coulombe P; Gagné B; Mérand Y; Moore S; Barden N
    Endocrinology; 1981 Jun; 108(6):2039-45. PubMed ID: 6164545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of cerebral noradrenaline turnover by thyrotropin-releasing hormone: evidence by fluorescence histochemistry.
    Constantinidis J; Geissbühler F; Gaillard JM; Hovaguimian T; Tissot R
    Experientia; 1974 Oct; 30(10):1182-3. PubMed ID: 4215671
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of intraventricular administration of glutaurine on norepinephrine, dopamine and serotonin turnover in different brain regions in rats.
    Feuer L; Fekete M; Kádár T; Telegdy G
    Acta Physiol Hung; 1983; 61(3):163-7. PubMed ID: 6650186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MK-771 enhances the turnover of norepinephrine in brain.
    Rastogi RB; Singhal RL
    Res Commun Chem Pathol Pharmacol; 1981 Jul; 33(1):187-90. PubMed ID: 6115460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone.
    Reigle TG; Avni J; Platz PA; Schildkraut JJ; Plotnikoff NP
    Psychopharmacologia; 1974 Jun; 37(1):1-6. PubMed ID: 4213267
    [No Abstract]   [Full Text] [Related]  

  • 15. [Noradrenaline metabolism in the brain of rolling mouse Nagoya and the influence of thyrotropin releasing hormone (author's transl)].
    Konagaya M; Takayanagi T; Muroga T; Adachi K; Sobue I
    Rinsho Shinkeigaku; 1980 Mar; 20(3):181-8. PubMed ID: 6103773
    [No Abstract]   [Full Text] [Related]  

  • 16. Brain dopamine-beta-hydroxylase activity in vivo: pharmacological, endocrinological, and psychological implications for adaptation.
    Stalk JM; Kaufman ME; Hanlon DP; Barchas JD; Nisula BC
    Adv Biochem Psychopharmacol; 1975; 13():199-245. PubMed ID: 808107
    [No Abstract]   [Full Text] [Related]  

  • 17. Long-lasting selective depletion of brain serotonin by 5,6-dihydroxytryptamine.
    Baumgarten HG; Björklund A; Lachenmayer L; Nobin A; Stenevi U
    Acta Physiol Scand Suppl; 1971; 373():1-15. PubMed ID: 5291907
    [No Abstract]   [Full Text] [Related]  

  • 18. [Examination of the TRH-TSH axis].
    Escobar del Rey F
    Rev Iber Endocrinol; 1973; 20(117):235-67. PubMed ID: 4200231
    [No Abstract]   [Full Text] [Related]  

  • 19. Stimulation of TSH release and glucose oxidation in pituitaries from thyroidectomized rats by thyrotropin releasing factor (TRF).
    Dubovsky EV; Beschi RJ; Pittman JA; Lindsay RH
    Ala J Med Sci; 1973 Jul; 10(3):270-7. PubMed ID: 4203687
    [No Abstract]   [Full Text] [Related]  

  • 20. Interactions of the tripeptide pyroglutamyl-histidyl-proline amide (thyrotropin-releasing hormone) with brain norepinephrine metabolism: evidence for an extrahypophyseal action of TRH on central nervous system function.
    Stolk JM; Nisula BC
    Prog Brain Res; 1975; 42():47-56. PubMed ID: 812145
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.